πŸ‡ΊπŸ‡Έ FDA
Patent

US 10759839

Cell-penetrating peptide

granted A61KA61K38/00A61K38/1758

Quick answer

US patent 10759839 (Cell-penetrating peptide) held by NEOREGEN BIOTECH expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NEOREGEN BIOTECH
Grant date
Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/1758